(RTTNews) - Thursday, Edwards Lifesciences (EW) announced that the U.S. FDA approved the AUTUS Size-Adjustable Valve, the first surgical pulmonary valve designed specifically for pediatric patients with congenital heart disease.
Publicznie pokazujemy glowna mysl. Utworz darmowe konto, aby czytac caly artykul, zapisac go, omowic i polaczyc z kontekstem rynkowym oraz OSINT.